Forecast: Basic Pharmaceutical Products and Pharmaceutical Preparations Output in the Netherlands

Analysis of the basic pharmaceutical products and pharmaceutical preparations output in the Netherlands reveals a consistent trend from 2013 to 2019, with the value holding steady at 0.4 units. A notable increase took place in 2020, where the value rose to 0.5 units, where it has remained steady through 2023 and is forecasted to continue through 2028. The year 2023 showed no change from the prior year.

The Compound Annual Growth Rate (CAGR) highlights an interesting progression, with a decline of -4.36% observed from 2013 to 2017 due to consistent zero growth year-on-year. The stability observed from 2018 to 2019 marks a neutral CAGR of 0%. A surge in 2020 results in a positive CAGR of 4.56% over the next few years, indicating an upturn in output. Forecasts show this stable trend continuing through 2028 with a 0% forecasted CAGR.

Future trends to watch for include potential market disruptions through technological advancements, regulatory changes, or shifts in global demand for pharmaceuticals, all of which could impact the forecasted steady state.